CompanyScope

IDEXX Laboratories Inc. income statement & cash flow

Ticker IDXX · SEC CIK 874716 · Latest fiscal year ended Dec 31, 2025

In the fiscal year ended Dec 31, 2025, IDEXX Laboratories Inc. reported net income of $1.06B on revenue of $4.30B. Operating cash flow was $1.18B and capital expenditures were $124.68M, leaving $1.06B of free cash flow (operating cash flow minus capital expenditures).

$0$500M$1B$2BDec 2016: $222.04MDec 2017: $263.14MDec 2018: $377.03MDec 2019: $427.72MDec 2020: $581.78MDec 2021: $744.85MDec 2022: $679.09MDec 2023: $845.04MDec 2024: $887.87MDec 2025: $1.06BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
IDEXX Laboratories Inc. net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year endedDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue (USD)$1.78B$1.97B$2.21B$2.41B$2.71B$3.22B$3.37B$3.66B$3.90B$4.30B
Gross profit (USD)$975.44M$1.10B$1.24B$1.37B$1.57B$1.89B$2.00B$2.19B$2.38B$2.66B
Operating income (USD)$350.24M$413.03M$491.33M$552.85M$694.52M$932.03M$898.76M$1.10B$1.13B$1.36B
Net income (USD)$222.04M$263.14M$377.03M$427.72M$581.78M$744.85M$679.09M$845.04M$887.87M$1.06B
Diluted EPS (USD per share)$2.44$2.94$4.26$4.89$6.71$8.60$8.03$10.06$10.67$13.08
Operating cash flow (USD)$338.94M$373.28M$400.08M$459.16M$648.06M$755.55M$542.98M$906.51M$929.00M$1.18B
Capital expenditures (USD)$64.79M$74.38M$115.75M$154.97M$106.96M$119.55M$148.84M$133.63M$120.92M$124.68M
Reported in10-K 201910-K 202010-K 202110-K 202210-K 202310-K 202410-K 202510-K 202610-K 202610-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year endedGross marginOperating marginNet margin
Dec 202561.8%31.6%24.6%
Dec 202461.0%29.0%22.8%
Dec 202359.8%30.0%23.1%
Dec 202259.5%26.7%20.2%
Dec 202158.8%29.0%23.2%
$0$500M$1B$2BDec 2016: $338.94MDec 2017: $373.28MDec 2018: $400.08MDec 2019: $459.16MDec 2020: $648.06MDec 2021: $755.55MDec 2022: $542.98MDec 2023: $906.51MDec 2024: $929.00MDec 2025: $1.18BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
IDEXX Laboratories Inc. operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 874716 (raw data). Most recent filing in this dataset: 10-Q filed Nov 2, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.